Mr Mark Feneley

Dr Mark FeneleyTel: 020 3447 9194
Fax: 020 3447 9303

University College Hospital

Bladder Cancer, Urological Cancers, Urology

Professional background

Consultant Urologist in Urological Oncology, Middlesex Hospital, London, from 2003. Senior Lecturer, UCL, 2004-2010. Clinical Lead for Urology (2008–2009), Lead for Urological Oncology (2003-2006), Lead for Bladder Cancer in the North Thames Cancer Network (2003-2009), Lead for Undergraduate Education in Urology (2006-2008) and past Lead Clinical Investigator in molecular biology at Prostate Cancer Research Centre, London. Consultant Urologist, Nottingham City Hospital 2000-2002, Director of Postgraduate Education. Clinical Post-Doctoral Fellowship in Urological Oncology, at the James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA (1998-2000). Higher urological training at St Bartholomew’s and Royal London Hospitals (1992-1998). University of Cambridge medical Qualification (1987) and MD degree (Detection and Assesment of Early Prostate Cancer, 1996).

Research interests

  • Diagnosis and treatment of non-muscle invasive bladder cancer, including photodynamic diagnosis, intravesical BCG, Mitomycin-C (passive, electromotive and hyperthermia)
  • Treatment of benign prostatic hyperplasia, including laser treatment (Greenlight ™, and Thulium 150 ™)


Whole Textbooks:
Prostate Cancer: Principles and Practice. Eds AW Partin, R S Kirby, M R Feneley, J K Parsons. Martin Dunitz. 2005. BMA Book Award Commendation, 2006. 
Therapeutic Opportunities in Prostate Cancer, Eds M R Feneley and H Payne. Clinical Publishing. 2007.  
Treatment Methods for Early and Advanced Prostate Cancer. Eds AW Partin, R S Kirby, J K Parsons, M R Feneley. Informa ( 2008). 
Handbook of Urological Surgery. Eds J Reynard, M Sullivan, K Turner, M R Feneley, N Armenakas, S Mark. OUP (2008).   
Journal Issues: 
Prostate Cancer: Clinical Outcomes in Clinical Practice. Surg Oncol (2009), 18S (3), 181-288 . Ed M R Feneley. 
Surgical Palliation in Malignant Disease. Clinical Oncology (2010). Ed M R Feneley.

GMC/GDC number: 3133220